Europe Clears Diabetes Drug - by Althea Chang
European regulators approved the drug Byetta from Eli Lilly.Byetta is designed to enhance blood-sugar control in patients who haven't seen an adequate improvement using the maximum tolerated doses of the commonly used drugs metformin or sulfonylurea. The approval follows a positive opinion issued by the Committee for Medicinal Products for Human Use at the European Medicines Agency. The regulators based their decision on data from 35 studies on nearly 4,000 individuals with type 2 diabetes.
The clinical results showed that the drug helped patients improve long-term blood-sugar control by lowering both fasting and post-meal glucose levels. Patients also lost weight thanks to their treatment.
No comments:
Post a Comment